Huijuan Xu

Title: Huijuan Xu: Innovator in Sustained-Release Drug Delivery

Introduction

Huijuan Xu is a notable inventor based in Zhuhai, China. He has made significant contributions to the field of pharmaceutical technology, particularly in drug delivery systems. His innovative work focuses on the development of sustained-release formulations that enhance therapeutic efficacy.

Latest Patents

One of Huijuan Xu's key patents is for an "Aripiprazole sustained-release microsphere and preparation method therefor." This invention provides a novel microsphere formulation that comprises aripiprazole and polylactide-glycolide. The microsphere features a spherical reticular skeleton structure with reticular micropores distributed across its surface, allowing for the encapsulation of aripiprazole within these micropores. The average particle diameter of the microsphere is less than 20 μm, making it suitable for administration through a 5 gauge needle. The content of aripiprazole in the microsphere ranges from 65% to 80% of its total weight, showcasing its potential for effective drug delivery.

Career Highlights

Huijuan Xu is associated with Zhuhai Livzon Microsphere Technology Co. Ltd., where he continues to advance his research and development efforts. His work has garnered attention for its innovative approach to drug formulation, particularly in the context of sustained-release technologies.

Collaborations

Huijuan Xu collaborates with several talented individuals in his field, including Bin Chen and Xia Yin. These partnerships enhance the research and development process, fostering an environment of innovation and creativity.

Conclusion

Huijuan Xu's contributions to the field of sustained-release drug delivery exemplify the importance of innovation in pharmaceutical technology. His patented work on aripiprazole microspheres represents a significant advancement in drug formulation, with the potential to improve patient outcomes.